Bitcoin Update: Bitcoin Price Drops Below $400

In what seems like a development which is the latest blow to bitcoin prices, Bitcoin prices have slumped to its lowest level since May late last week. The decline has since been largely attributed to a worsening short-term news outlook, as well as the industry’s margin traders, though alternative theories have been proposed.

At press time, at least one notable industry analyst, along with a host of exchange users are suggesting that margin trading may have once again played a factor in today’s decline, as a flash crash observed on popular bitcoin trading platform BTC-e caused the price of bitcoin on its exchange to decline sharply to a low of $309.

That price was observed on BTC-e at roughly 07:36 (UTC), and was followed by similar declines across other major bitcoin trading platforms including Bitstamp, Huobi and OKCoin, market analysis shows. Notably, this is not the first time such a large flash crash has been observed on BTC-e. For example, this February, the price on the exchange declined nearly $500 in just over one minute.

News on Bitcoins

Data analysis shows other major exchanges soon responded to declining prices observed on BTC-e, with a sharp drop observed across their order books at roughly 07:37 (UTC). By 07:46, the price of bitcoin on Bitstamp began its decline, landing roughly $20 below its starting point to touch $462.01 and hitting a daily low price of $442 at roughly 08:51.

Major China-based Huobi and OKCoin also recorded less notable drops during this time. For example, Huobi’s price decline began at 07:37, dropping from ¥2880.1 to ¥2788.1 by 07:45. Likewise, OKCoin saw prices on its exchange fall from ¥2880.4 at 07:36 to ¥2785.3 by 07:45.

Bitcoin News Video

Watch this video for more “News on Bitcoin”.

Continue reading “Bitcoin Update: Bitcoin Price Drops Below $400”

Google Plans Services For Children, What Impact for GOOG Stock?

Google Inc (NASDAQ GOOG) has announced that it will expand its target audience to include kids under the age of 13, by offering accounts to children for its products like YouTube and Gmail. The company will allow parents to set up accounts for their children and control the data children can access through a dashboard. This is a bold move by the tech giant in … Continue reading Google Plans Services For Children, What Impact for GOOG Stock?

Biotech News: Top Stocks Review For The Week

The trading session has ended on a higher note as the Dow Jones Industrial Average finished at 16,569.98, up 0.10% and the NASDAQ Composite closed at 4,401.33, up 0.70%. The S&P 500 finished the day 0.28% higher at 1,936.92. During the trading session seven out of ten sectors finished on a positive note. The S&P 500 Health Care Sector Index finished the day at 700.04, … Continue reading Biotech News: Top Stocks Review For The Week

AAPL NASDAQ AAPL Apple Inc

AAPL Stock in Focus: Apple Reaches $100 Levels

Apple Inc (NASDAQ AAPL) stock is back up at a level it hasn’t seen in over a year (on a split adjusted basis). This is the first time the company’s shares passed $100 since the seven for one stock split. Analysts from both RBC and Morgan Stanley are touting Apple’s upcoming products. The RBC team thinks the iPhone 6 will be even bigger than anyone … Continue reading AAPL Stock in Focus: Apple Reaches $100 Levels

FB Messenger App Poised to Shine (Facebook News)

The unwanted Facebook Messenger app has been downloaded more than 500 million times on Android. Even though users were initially irritated by Facebook Inc (NASDAQ FB)’s separation of messaging from its basic app, they’re apparently not too worried about it after all. The app tops the charts for most downloaded in both Google Inc (NASDAQ GOOG)’s Play Store and Apple Inc (NASDAQ AAPL)’s list of … Continue reading FB Messenger App Poised to Shine (Facebook News)

Active Biotech Stock: A Look at Mannkind Corp

Shares of MannKind Corp. have been on a wild ride over the past year. Most of this volatility is the result of emotionally-charged retail investors pushing the stock past realistic valuation levels. This stock serves as another glaring example as to why it’s generally a bad idea to follow the crowd when investing in biotech stocks. MannKind Corp. (NASDAQ MNKD) is the latest cult biotech … Continue reading Active Biotech Stock: A Look at Mannkind Corp